INOVAIT to Announce Latest Pilot Fund Recipients at ALL IN 2025

TORONTO--(BUSINESS WIRE)--INOVAIT, Canada’s membership network promoting image-guided therapy (IGT) and artificial intelligence (AI) technology innovations, announced that they will present their latest Pilot Fund recipients at SCALE AI’s 2025 ALL IN event at the Palais des congrès in Montreal, Quebec, from September 24-25.

The Pilot Fund is a non-dilutive funding program facilitated by INOVAIT. It provides up to $125,000 in contributions for research and development (R&D) projects lasting 9 to 15 months. The Pilot Fund promotes the commercial translation of R&D within the medical device and digital health sectors. These projects have the potential to transform patient outcomes and reduce the overall cost of healthcare in Canada.

About INOVAIT
INOVAIT is Canada’s image-guided therapy (IGT) and artificial intelligence (AI) network. INOVAIT supports Canadian IGT companies and academic institutions to go faster and farther to build and validate medical technologies, positively impact the healthcare system, and create high-quality jobs. The network brings together small, medium-sized, and large companies, research organizations, post-secondary institutions, and not-for-profit organizations to collaborate on game-changing projects to transform healthcare. INOVAIT strengthens the Canadian IGT ecosystem by fuelling continuous innovation that revolutionizes healthcare globally. INOVAIT was established in 2020 by Sunnybrook Research Institute and supported by the Government of Canada’s Strategic Innovation Fund.